SL-25.1188 | m-entrepreneurship.com

Product Name :
SL-25.1188

Search keywords :
SL-25.1188

drugId :
null

Target Vo:
Monoamine oxidase B

Target Vo Short Name :
MAOB

Moa_Name:
Monoamine oxidase B inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Sanofi

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Alzheimer Disease

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Proteasome 20S LMP7 Antibody
Rb Antibody
Cyclin A1 Antibody: Cyclin A1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 52 kDa, targeting to Cyclin A1. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat, Monkey.

Author: Betaine hydrochloride

Related Posts